216 related articles for article (PubMed ID: 16429378)
1. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid.
Ormazabal A; Artuch R; Vilaseca MA; Aracil A; Pineda M
Neuropediatrics; 2005 Dec; 36(6):380-5. PubMed ID: 16429378
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment.
Temudo T; Rios M; Prior C; Carrilho I; Santos M; Maciel P; Sequeiros J; Fonseca M; Monteiro J; Cabral P; Vieira JP; Ormazabal A; Artuch R
Brain Dev; 2009 Jan; 31(1):46-51. PubMed ID: 18572337
[TBL] [Abstract][Full Text] [Related]
3. HPLC with electrochemical and fluorescence detection procedures for the diagnosis of inborn errors of biogenic amines and pterins.
Ormazabal A; García-Cazorla A; Fernández Y; Fernández-Alvarez E; Campistol J; Artuch R
J Neurosci Methods; 2005 Mar; 142(1):153-8. PubMed ID: 15652629
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome.
Ramaekers VT; Sequeira JM; Artuch R; Blau N; Temudo T; Ormazabal A; Pineda M; Aracil A; Roelens F; Laccone F; Quadros EV
Neuropediatrics; 2007 Aug; 38(4):179-83. PubMed ID: 18058624
[TBL] [Abstract][Full Text] [Related]
5. Reduced folate transport to the CNS in female Rett patients.
Ramaekers VT; Hansen SI; Holm J; Opladen T; Senderek J; Häusler M; Heimann G; Fowler B; Maiwald R; Blau N
Neurology; 2003 Aug; 61(4):506-15. PubMed ID: 12939425
[TBL] [Abstract][Full Text] [Related]
6. Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion.
Pineda M; Ormazabal A; López-Gallardo E; Nascimento A; Solano A; Herrero MD; Vilaseca MA; Briones P; Ibáñez L; Montoya J; Artuch R
Ann Neurol; 2006 Feb; 59(2):394-8. PubMed ID: 16365882
[TBL] [Abstract][Full Text] [Related]
7. Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid.
Botez MI; Young SN
Brain; 1991 Feb; 114 ( Pt 1A)():333-48. PubMed ID: 1705463
[TBL] [Abstract][Full Text] [Related]
8. Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: a randomized study.
Hagebeuk EE; Duran M; Koelman JH; Abeling NG; Vyth A; Poll-The BT
J Child Neurol; 2012 Mar; 27(3):304-9. PubMed ID: 21868372
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid studies in the Rett syndrome: biogenic amines and beta-endorphins.
Budden SS; Myer EC; Butler IJ
Brain Dev; 1990; 12(1):81-4. PubMed ID: 1693044
[TBL] [Abstract][Full Text] [Related]
10. Biochemical diagnosis of dopaminergic disturbances in paediatric patients: analysis of cerebrospinal fluid homovanillic acid and other biogenic amines.
Marín-Valencia I; Serrano M; Ormazabal A; Pérez-Dueñas B; García-Cazorla A; Campistol J; Artuch R
Clin Biochem; 2008 Nov; 41(16-17):1306-15. PubMed ID: 18790694
[TBL] [Abstract][Full Text] [Related]
11. Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of paediatric patients: reference values for a paediatric population.
Ormazabal A; García-Cazorla A; Pérez-Dueñas B; Gonzalez V; Fernández-Alvarez E; Pineda M; Campistol J; Artuch R
Clin Chim Acta; 2006 Sep; 371(1-2):159-62. PubMed ID: 16624264
[TBL] [Abstract][Full Text] [Related]
12. Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies.
Ramaekers VT; Thöny B; Sequeira JM; Ansseau M; Philippe P; Boemer F; Bours V; Quadros EV
Mol Genet Metab; 2014 Dec; 113(4):307-14. PubMed ID: 25456743
[TBL] [Abstract][Full Text] [Related]
13. Cerebral folate deficiency syndromes in childhood: clinical, analytical, and etiologic aspects.
Pérez-Dueñas B; Ormazábal A; Toma C; Torrico B; Cormand B; Serrano M; Sierra C; De Grandis E; Marfa MP; García-Cazorla A; Campistol J; Pascual JM; Artuch R
Arch Neurol; 2011 May; 68(5):615-21. PubMed ID: 21555636
[TBL] [Abstract][Full Text] [Related]
14. Clinical and electroencephalographic effects of folinic acid treatment in Rett syndrome patients.
Hagebeuk EE; Koelman JH; Duran M; Abeling NG; Vyth A; Poll-The BT
J Child Neurol; 2011 Jun; 26(6):718-23. PubMed ID: 21427443
[TBL] [Abstract][Full Text] [Related]
15. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients.
Stiasny-Kolster K; Möller JC; Zschocke J; Bandmann O; Cassel W; Oertel WH; Hoffmann GF
Mov Disord; 2004 Feb; 19(2):192-6. PubMed ID: 14978675
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
Vezmar S; Schüsseler P; Becker A; Bode U; Jaehde U
Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
[TBL] [Abstract][Full Text] [Related]
17. Spinal fluid 5-methyltetrahydrofolate levels are normal in Rett syndrome.
Neul JL; Maricich SM; Islam M; Barrish J; Smith EO; Bottiglieri T; Hyland K; Humphreys P; Percy A; Glaze D
Neurology; 2005 Jun; 64(12):2151-2. PubMed ID: 15985595
[No Abstract] [Full Text] [Related]
18. Low CSF HVA levels in the Rett syndrome: a reflection of restricted synapse formation?
Nielsen JB; Bertelsen A; Lou HC
Brain Dev; 1992 May; 14 Suppl():S63-5. PubMed ID: 1378245
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome: a new phenotype.
Blau N; Bonafé L; Krägeloh-Mann I; Thöny B; Kierat L; Häusler M; Ramaekers V
Neurology; 2003 Sep; 61(5):642-7. PubMed ID: 12963755
[TBL] [Abstract][Full Text] [Related]
20. Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome.
Matsuishi T; Nagamitsu S; Yamashita Y; Murakami Y; Kimura A; Sakai T; Shoji H; Kato H; Percy AK
Ann Neurol; 1997 Dec; 42(6):978-81. PubMed ID: 9403492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
